Literature DB >> 21286942

Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound.

L Camera1, S Paoletta, C Mollica, F Milone, V Napolitano, L De Luca, A Faggiano, A Colao, M Salvatore.   

Abstract

PURPOSE: The authors compared multidetector-row computed tomography (MDCT) and endoscopic ultrasound (EUS) in the identification of pancreaticoduodenal endocrine tumours (PETs) in patients with multiple endocrine neoplasia type 1 (MEN 1).
MATERIALS AND METHODS: Fourteen consecutive patients (eight men and six women, aged 26-54 years) with MEN 1 underwent MDCT performed with a 4- (n=5) or 64- (n=9) detector-row system and EUS done with a radial transducer (7.5-20 MHz) within 7-28 days of each other. Prior to MDCT examination, patients were given 750 cc of water and asked to lie down in the right lateral decubitus for 15 min. Multiphase MDCT images were acquired both before and after the injection of nonionic iodinated contrast material (2 cc/kg) at an injection rate of 4 ml/s, with technical parameters and scan delay varying in relation to the system used. Images were all reconstructed at 3-mm intervals for the three phases (arterial, pancreatic and portal) and evaluated on a dedicated workstation.
RESULTS: MDCT detected a total of 25 PETs (3-18 mm) in nine patients. Of these lesions, nine were situated within the duodenal wall and 16 in either the pancreatic head (n=3), body (n=7), or tail (n=6). Three additional lesions were detected retrospectively after EUS imaging. Most (18/22, 81%) were hypervascular nodules, and four appeared as either hypoattenuating or cystic lesions. EUS detected a total of 32 PETs (2-18 mm) in 11 patients. Most lesions (29/32, 90%) appeared hypoechoic and were situated in the duodenal wall (n=15) or in either the pancreatic head (n=10), body (n=6) or tail (n=1).
CONCLUSIONS: Our preliminary data indicate that MDCT is complementary to EUS in the identification of PETs in MEN-1 patients.

Entities:  

Mesh:

Year:  2011        PMID: 21286942     DOI: 10.1007/s11547-011-0636-2

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  22 in total

1.  Optimization of automatic bolus tracking for timing of the arterial phase of helical liver CT.

Authors:  J J Sandstede; A Tschammler; M Beer; C Vogelsang; G Wittenberg; D Hahn
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 2.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

Review 3.  Imaging of neuroendocrine gastroenteropancreatic tumours.

Authors:  R Graziani; A Brandalise; M Bellotti; R Manfredi; A Contro; M Falconi; L Boninsegna; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2010-03-09       Impact factor: 3.469

4.  Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Laurence Thomas-Marques; Arnaud Murat; Brigitte Delemer; Alfred Penfornis; Catherine Cardot-Bauters; Eric Baudin; Patricia Niccoli-Sire; Damien Levoir; Hélène du Boullay Choplin; Olivier Chabre; Nicolas Jovenin; Guillaume Cadiot
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

5.  Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Peter Langer; Peter H Kann; Volker Fendrich; Gerd Richter; Saskia Diehl; Matthias Rothmund; Detlef K Bartsch
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

6.  Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1.

Authors:  P Hellman; J Hennings; G Akerström; B Skogseid
Journal:  Br J Surg       Date:  2005-12       Impact factor: 6.939

7.  The value of multidetector-row CT in the preoperative detection of pancreatic insulinomas.

Authors:  Y Liu; Q Song; H T Jin; X Z Lin; K M Chen
Journal:  Radiol Med       Date:  2009-09-30       Impact factor: 3.469

8.  Pitfalls in endosonographic imaging of suspected insulinomas: pancreatic nodules of unknown dignity.

Authors:  P H Kann; B Wirkus; A Keth; K Goitom
Journal:  Eur J Endocrinol       Date:  2003-05       Impact factor: 6.664

9.  CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas.

Authors:  Hervé Gouya; Olivier Vignaux; Joelle Augui; Bertrand Dousset; Laurent Palazzo; André Louvel; Stanislas Chaussade; Paul Legmann
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

10.  Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1.

Authors:  L Benson; S Ljunghall; G Akerström; K Oberg
Journal:  Am J Med       Date:  1987-04       Impact factor: 4.965

View more
  4 in total

1.  Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma.

Authors:  Luigi Camera; Rosa Severino; Antongiulio Faggiano; Stefania Masone; Gelsomina Mansueto; Simone Maurea; Rosa Fonti; Marco Salvatore
Journal:  World J Radiol       Date:  2014-10-28

2.  Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Secondo Lastoria; Francesca Marciello; Antongiulio Faggiano; Luigi Aloj; Corradina Caracò; Michela Aurilio; Laura D'Ambrosio; Francesca Di Gennaro; Valeria Ramundo; Luigi Camera; Leonardo De Luca; Rosa Fonti; Vincenzo Napolitano; Annamaria Colao
Journal:  Endocrine       Date:  2015-08-05       Impact factor: 3.633

3.  Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy.

Authors:  Francesco Izzo; Vincenza Granata; Roberta Fusco; Valeria D'Alessio; Antonella Petrillo; Secondo Lastoria; Mauro Piccirillo; Vittorio Albino; Andrea Belli; Salvatore Tafuto; Antonio Avallone; Renato Patrone; Raffaele Palaia
Journal:  J Clin Med       Date:  2021-03-22       Impact factor: 4.241

Review 4.  Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base.

Authors:  Mark J C van Treijen; Dirk-Jan van Beek; Rachel S van Leeuwaarde; Menno R Vriens; Gerlof D Valk
Journal:  J Endocr Soc       Date:  2018-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.